Contrary, Krutikov et al. [135] found an augmentation of EPCs (CD34+ CD133+/CD34+ CD133+ KDR+) levels in PAD-DM patients as compared with DM patients without PAD, being similar to the levels found in HC. This evidence concerns the gene PROM1 and diabetes mellitus.